ID   I3.4.2
AC   CVCL_B0GV
SY   T42402I3.4.2
DR   Wikidata; Q108820521
RX   Patent=US7252992;
RX   PubMed=16524757;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5201.
CC   Population: Caucasian.
CC   Characteristics: High expression of MCHR1. Responds to melanin-concentrating hormone (MCH) in Calcium-mobilization assays (PubMed=16524757).
CC   Transfected with: HGNC; 4383; GNA15.
CC   Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
RX   Patent=US7252992;
RA   Fry D.G., Collins C.A., Dayton B.D.;
RT   "Cell line and uses thereof.";
RL   Patent number US7252992, 07-Aug-2007.
//
RX   PubMed=16524757; DOI=10.1016/j.biocel.2006.01.007;
RA   Fry D.G., Dayton B.D., Brodjian S.J., Ogiela C., Sidorowicz H.,
RA   Frost L.J., McNally T., Reilly R.M., Collins C.A.;
RT   "Characterization of a neuronal cell line expressing native human
RT   melanin-concentrating hormone receptor 1 (MCHR1).";
RL   Int. J. Biochem. Cell Biol. 38:1290-1299(2006).
//